Clinical Trials Browser

Phase 1/2 × Suspended × Ovarian Neoplasms × Clear all

Bile Duct Neoplasms, Breast Neoplasms, Gallbladder Neoplasms, Ovarian Neoplasms, Prostatic Neoplasms, Sarcoma, Vulvar Neoplasms, Carcinoma, Neuroendocrine, Neuroendocrine Tumors

NCT04042116 2022-12-20

A Study to Evaluate Lucitanib in Combination With Nivolumab in Patients With a Solid Tumor

Phase 1/2 Suspended

227 enrolled

Gynecologic

Uterine Cervical Neoplasms, Fallopian Tube Neoplasms, Genital Neoplasms, Female, Ovarian Neoplasms, Endometrial Neoplasms

NCT03393962 2018-07-31

Intervention of Ovarian Cancer With Antigen-specific Engineered Immune Effectors

Phase 1/2 Suspended

20 enrolled

Gynecologic

Ovarian Neoplasms

Clinical Trials

Atezolizumab Plus Tivozanib in Immunologically Cold Tumor Types

A Study to Evaluate Lucitanib in Combination With Nivolumab in Patients With a Solid Tumor

Intervention of Ovarian Cancer With Antigen-specific Engineered Immune Effectors